Michael Robert Martin - Chief Business Officer at Aurinia Pharmaceuticals Inc.

Insider Transactions and Holdings

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	259K	$2.92M	$11.26	Mar 2, 2023	Direct

Showing 1 to 1 of 1 entries

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.